|
1) 図説 わが国の慢性透析療法の現況 2009年12月31日現在. 日本透析医学会. 2010
|
|
|
|
|
2) 2009年版日本透析医学会. 腹膜透析ガイドライン. 透析会誌. 2009; 42: 285-315
|
|
|
|
|
|
3) Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010; 12: 363(7): 609-19
|
|
|
|
|
|
4) Chow KM, Szeto CC, Law MC, et al. Impact of early nephrology referral on mortality and hospitalization in peritoneal dialysis patients. Peritoneal Dialysis International. 2008; 28: 371-6
|
|
|
|
|
5) Shiao CC, Huang JW, Chien KL, et al. Early initiation of dialysis and late implantation of catheters adversely affect outcomes of patients on chronic peritoneal dialysis. Perit Dial Int. 2008; 28: 73-81
|
|
|
|
|
|
6) Dombros N, Dratwa M, Feriani M, et al. EBPG Expert Group on Peritoneal Dialysis. European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis. Nephrol Dial Transplant. 2005; 20 Suppl 9: ix3-ix7
|
|
|
|
|
|
7) Peritoneal Dialysis Adequacy Work Group. Clinical practice guidelines and clinical practice recommendations 2006 update. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 2006; 48 Suppl 1: S98-129
|
|
|
|
|
|
8) 川口良人, 二瓶 宏, 平沢由平, 他. 透析導入ガイドラインの作成に関する研究. 平成3年度厚生科学研究・腎不全医療研究事業報告書: 1991. p.125-32
|
|
|
|
|
|
9) Hakim R, Lazarus J. Initiation of dialysis. J Am Soc Nephrol. 1995; 6: 1319-28
|
|
|
|
|
|
10) Churchill DN. An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis. 1997; 30: 899-906
|
|
|
|
|
11) Rosansky SJ, Clark WF, Eggers P, Glassock RJ. Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful？ Kidney Int. 2009; 76: 257-61. Epub 2009 May 20
|
|
|
|
|
|
12) Bargman JM, Thorpe KE, Churchill DN. CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001; 12: 2158-62
|
|
|
|
|
|
13) Termorshuizen F, Korevaar JC, Dekker FW, et al. NECOSAD Study Group. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis. 2003; 41: 1293-302
|
|
|
|
|
|
14) Cooper BA, Branley P, Bulfone L, et al. IDEAL Study Steering Committee. The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int. 2004; 24: 176-81
|
|
|
|
|
|
15) Wright S, Klausner D, Baird B, et al. Timing of dialysis initiation and survival in ESRD. Clin J Am Soc Nephrol. 2010 [Epub ahead of print]
|
|
|
|
|
|
16) Hwang SJ, Yang WC, Lin MY, et al. Taiwan Society of Nephrology. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan. Nephrol Dial Transplant. 2010; 25: 2616-24. Epub 2010 Jun 2
|
|
|
|
|
|
17) Stel VS, Dekker FW, Ansell D, et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant. 2009; 24: 3175-82. Epub 2009 Jun 10
|
|
|
|
|
|
18) Lassalle M, Labeeuw M, Frimat L, et al. Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival 2010. Kidney International. 2010; 77: 700-7
|
|
|
|
|
|
19) Lameire N, Van Biesen W. The Initiation of renal-replacement therapy- just-in-time delivery. N Engl J Med. 2010; 363: 678-80
|
|
|
|
|
|
20) Churchill DN, Thorpe KE, Nolph KD, et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1998; 9: 1285-92
|
|
|
|
|
|
21) NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis. 2001; 37: S65-S136
|
|
|
|
|
|
22) Fan SL, Pile T, Punzalan S, et al. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int. 2008; 73: 200-6. Epub 2007 Oct 3
|
|
|
|
|
|
23) Szeto CC, Chow KM, Lam CW, et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products-a 1-year randomized control trial. Nephrol Dial Transplant. 2007; 22: 552-9. Epub 2006 Sep 27
|
|
|
|
|
|
24) Haag-Weber M, Krämer R, Haake R, et al. Behalf of the DIUREST Study Group. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant. 2010; 25: 2288-96
|
|
|
|
|
|
25) Kim SG, Kim S, Hwang YH, et al. Korean Balnet Study Group. Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients？ A 1-year multicenter prospective randomized controlled trial (Balnet Study). Perit Dial Int. 2008; 28 Suppl 3: S117-22
|
|
|
|
|
|
26) Jansen MA, Hart AA, Korevaar JC, et al. NECOSAD Study Group. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002; 62: 1046-53
|
|
|
|
|
|
27) Lo WK, Bargman JM, Burkart J, et al. ISPD Adequacy of Peritoneal Dialysis Working Group. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006; 26: 520-2
|
|
|
|
|
|
28) Van Biesen W, Vanholder R, Lameire N. The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int. 2000; 20: 375-83
|
|
|
|
|
|
29) Blake PG. Integrated end-stage renal disease care: the role of peritoneal dialysis. Nephrol Dial Transplant. 2001; 16 Suppl 5: 61-6
|
|
|
|
|
|
30) Jaar BG, Coresh J, Plantinga LC, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med. 2005; 143: 174-83
|
|
|
|
|
|
31) McDonald SP, Marshall MR, Johnson DW, et al. Relationship between dialysis modality and mortality. J Am Soc Nephrol. 2009; 20: 155-63. Epub 2008 Dec 17
|
|
|
|
|
|
32) Lee HY, Park HC, Seo BJ, et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int. 2005; 25: 248-55
|
|
|
|
|